• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估富亮氨酸、胶质瘤失活 1 抗体相关脑炎的认知缺陷和结构海马损伤。

Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.

机构信息

Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany2Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany3Berlin Center for Advanced Neuroimaging, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany4German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.

出版信息

JAMA Neurol. 2017 Jan 1;74(1):50-59. doi: 10.1001/jamaneurol.2016.4226.

DOI:10.1001/jamaneurol.2016.4226
PMID:27893017
Abstract

IMPORTANCE

Limbic encephalitis with leucine-rich, glioma-inactivated 1 (LGI1) antibodies is one of the most frequent variants of autoimmune encephalitis with antibodies targeting neuronal surface antigens. However, the neuroimaging pattern and long-term cognitive outcome are not well understood.

OBJECTIVE

To study cognitive outcome and structural magnetic resonance imaging (MRI) alterations in patients with anti-LGI1 encephalitis.

DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study was conducted at the Departments of Neurology at Charité-Universitätsmedizin Berlin and University Hospital Schleswig-Holstein, Kiel, Germany. Data on 30 patients with anti-LGI1 encephalitis and 27 healthy control individuals matched for age, sex, and educational level were collected from June 1, 2013, through February 28, 2015.

MAIN OUTCOMES AND MEASURES

Clinical assessment, cognitive testing, and high-resolution MRI data, including whole-brain, hippocampal and basal ganglia volumetry; white matter integrity (diffusion tensor imaging); gray matter density (voxel-based morphometry); and hippocampal microstructural integrity (mean diffusivity and fractional anisotropy).

RESULTS

Of the 30 patients included in the study, 19 were male (63%); mean (SD) age was 65.7 (12.3) years. Patients with anti-LGI1 encephalitis had incomplete recovery with significant and persisting verbal (mean [SE] Rey Auditory Verbal Learning Test [RAVLT], delayed recall: patients, 6.52 [1.05]; controls, 11.78 [0.56], P < .001) and visuospatial (Rey-Osterrieth Complex Figure Test [ROCF], delayed recall: patients, 16.0 [1.96]; controls, 25.86 [1.24]; P < .001) memory deficits. These deficits were accompanied by pronounced hippocampal atrophy, including subfields cornu ammonis 2/3 (CA2/3) and CA4/dentate gyrus (DG), as well as impaired hippocampal microstructural integrity. Higher disease severity correlated with larger verbal memory deficits (RAVLT delayed recall, r = -0.40; P = .049), decreased volumes of left hippocampus (r = -0.47; P = .02) and left CA2/3 (r = -0.41; P = .04) and CA4/DG (r = -0.43; P = .03) subfields, and impaired left hippocampal microstructural integrity (r = 0.47; P = .01). In turn, decreased volume of the left CA2/3 subfield (RAVLT delayed recall, r = 0.40; P = .047) and impaired left hippocampal microstructural integrity (RAVLT recognition, r = -0.41; P = .04) correlated with verbal memory deficits. Basal ganglia MRI signal abnormalities were observed in only 1 patient, but a longer duration of faciobrachial dystonic seizures correlated with a reduction of pallidum volume (r = -0.71; P = .03). In contrast, no abnormalities of cortical gray matter or white matter were found. The latency between disease onset and initiation of immunotherapy was significantly correlated with verbal (RAVLT recall after interference, r = -0.48; P = .02) and visuospatial (ROCF delayed recall, r = -0.46; P = .03) memory deficits.

CONCLUSIONS AND RELEVANCE

Anti-LGI1 encephalitis is associated with cognitive deficits and disability as a result of structural damage to the hippocampal memory system. This damage might be prevented by early immunotherapy.

摘要

重要性:富含亮氨酸的胶质瘤失活 1 抗体(LGI1)相关脑炎是抗神经元表面抗原自身免疫性脑炎最常见的变体之一。然而,神经影像学模式和长期认知结局尚不清楚。

目的:研究抗 LGI1 脑炎患者的认知结局和结构磁共振成像(MRI)改变。

设计、地点和参与者:这是一项在德国柏林夏洛蒂医科大学和石勒苏益格-荷尔斯泰因州基尔大学医院神经内科进行的横断面研究。从 2013 年 6 月 1 日至 2015 年 2 月 28 日,共收集了 30 例抗 LGI1 脑炎患者和 27 例年龄、性别和教育程度相匹配的健康对照者的数据。

主要结局和测量:临床评估、认知测试和高分辨率 MRI 数据,包括全脑、海马和基底节容积测量;白质完整性(弥散张量成像);灰质密度(基于体素的形态测量);和海马微观结构完整性(平均扩散系数和各向异性分数)。

结果:研究共纳入 30 例患者,其中 19 例为男性(63%);平均(SD)年龄为 65.7(12.3)岁。抗 LGI1 脑炎患者存在不完全恢复,存在明显且持续的言语( Rey 听觉言语学习测试 [RAVLT],延迟回忆:患者为 6.52[1.05],对照组为 11.78[0.56],P<0.001)和视觉空间( Rey-Osterrieth 复杂图形测试 [ROCF],延迟回忆:患者为 16.0[1.96],对照组为 25.86[1.24],P<0.001)记忆缺陷。这些缺陷伴随着明显的海马萎缩,包括 Cornu Ammonis 2/3(CA2/3)和 CA4/齿状回(DG)在内的海马亚区,以及海马微观结构完整性受损。疾病严重程度与言语记忆缺陷程度更高相关(RAVLT 延迟回忆,r=-0.40;P=0.049),左侧海马(r=-0.47;P=0.02)和左侧 CA2/3(r=-0.41;P=0.04)和 CA4/DG(r=-0.43;P=0.03)亚区的体积减小,以及左侧海马微观结构完整性受损(r=0.47;P=0.01)。反过来,左侧 CA2/3 亚区体积减小(RAVLT 延迟回忆,r=0.40;P=0.047)和左侧海马微观结构完整性受损(RAVLT 识别,r=-0.41;P=0.04)与言语记忆缺陷相关。仅在 1 例患者中观察到基底节 MRI 信号异常,但面肩肱型肌张力障碍性癫痫发作的持续时间较长与苍白球体积减小相关(r=-0.71;P=0.03)。相比之下,没有发现皮质灰质或白质的异常。疾病发作与免疫治疗开始之间的潜伏期与言语(RAVLT 干扰后回忆,r=-0.48;P=0.02)和视觉空间(ROCF 延迟回忆,r=-0.46;P=0.03)记忆缺陷显著相关。

结论和相关性:抗 LGI1 脑炎与认知缺陷和残疾有关,这是由于海马记忆系统的结构损伤所致。早期免疫治疗可能预防这种损伤。

相似文献

1
Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.评估富亮氨酸、胶质瘤失活 1 抗体相关脑炎的认知缺陷和结构海马损伤。
JAMA Neurol. 2017 Jan 1;74(1):50-59. doi: 10.1001/jamaneurol.2016.4226.
2
Clinical features of 28 cases of antileucinerich gliomainactivated protein 1 encephalitis and anticontactinassociated proteinlike 2 encephalitis.抗亮氨酸丰富的胶质瘤失活蛋白 1 脑炎和抗接触蛋白相关蛋白样 2 脑炎 28 例临床特征。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Mar 28;48(3):386-396. doi: 10.11817/j.issn.1672-7347.2023.220548.
3
Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.西班牙抗亮氨酸丰富胶质瘤失活蛋白 1(LGI1)脑炎治疗后的神经、精神和睡眠调查:一项前瞻性队列研究。
Lancet Neurol. 2024 Mar;23(3):256-266. doi: 10.1016/S1474-4422(23)00463-5.
4
Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis.LGI1电压门控性钾离子通道复合物抗体相关性边缘叶脑炎后海马CA3局部亚区萎缩
Brain. 2017 May 1;140(5):1212-1219. doi: 10.1093/brain/awx070.
5
The importance of early immunotherapy in patients with faciobrachial dystonic seizures.早期免疫疗法对面肩肱型肌阵挛癫痫患者的重要性。
Brain. 2018 Feb 1;141(2):348-356. doi: 10.1093/brain/awx323.
6
Hippocampal network abnormalities explain amnesia after VGKCC-Ab related autoimmune limbic encephalitis.海马网络异常解释了 VGKCC-Ab 相关自身免疫性边缘性脑炎后的遗忘。
J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):965-974. doi: 10.1136/jnnp-2018-320168. Epub 2019 May 9.
7
Neuropsychological and Structural Neuroimaging Outcomes in LGI1-Limbic Encephalitis: A Case Study.LGI1 型边缘性脑炎的神经心理学和结构神经影像学结果:病例研究。
Arch Clin Neuropsychol. 2023 Jan 21;38(1):139-153. doi: 10.1093/arclin/acac072.
8
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.面臂型发作性肌张力障碍:免疫疗法对发作控制和预防认知障碍的影响,表型不断扩大。
Brain. 2013 Oct;136(Pt 10):3151-62. doi: 10.1093/brain/awt212. Epub 2013 Sep 6.
9
Natural course of LGI1 encephalitis: 3-5 years of follow-up without immunotherapy.LGI1 脑炎的自然病程:未经免疫治疗的 3 - 5 年随访
J Neurol Sci. 2014 Aug 15;343(1-2):198-202. doi: 10.1016/j.jns.2014.05.048. Epub 2014 Jun 2.
10
Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.抗富含亮氨酸胶质瘤失活-1脑炎的临床特征、免疫治疗及预后
J Neuropsychiatry Clin Neurosci. 2022 Spring;34(2):141-148. doi: 10.1176/appi.neuropsych.20120303. Epub 2021 Nov 19.

引用本文的文献

1
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 Patients.抗LGI1脑炎的癫痫风险及与癫痫发作缓解时间相关的因素:236例患者的长期预后
Neurol Neuroimmunol Neuroinflamm. 2025 Nov;12(6):e200469. doi: 10.1212/NXI.0000000000200469. Epub 2025 Sep 15.
2
Altered effective connectivity in leucine-rich glioma-inactivated 1 antibody encephalitis: a spectral dynamic causal modeling study.富含亮氨酸胶质瘤失活1抗体脑炎中有效连接性的改变:一项频谱动态因果模型研究。
Psychoradiology. 2025 Aug 20;5:kkaf022. doi: 10.1093/psyrad/kkaf022. eCollection 2025.
3
Subcortical shape biomarkers reveal limbic and basal ganglia damage in anti-LGI1 encephalitis.
皮层下形态生物标志物揭示抗LGI1脑炎中的边缘系统和基底神经节损伤。
Front Immunol. 2025 Jul 4;16:1623577. doi: 10.3389/fimmu.2025.1623577. eCollection 2025.
4
Cognitive and Patient-Reported Outcome Measures in LGI-1-IgG Autoimmune Encephalitis.LGI-1-IgG自身免疫性脑炎中的认知及患者报告结局指标
Ann Clin Transl Neurol. 2025 Aug;12(8):1670-1679. doi: 10.1002/acn3.70105. Epub 2025 Jun 21.
5
Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort Study.抗LGI1抗体介导的脑炎的急性和长期免疫治疗策略:一项多中心队列研究
Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200412. doi: 10.1212/NXI.0000000000200412. Epub 2025 Jun 19.
6
Clinical, Electroencephalogram and Imaging Characteristics of Patients With Anti-LGI1 Antibody Encephalitis: A Multicenter Cohort Study.抗LGI1抗体脑炎患者的临床、脑电图及影像学特征:一项多中心队列研究
CNS Neurosci Ther. 2025 May;31(5):e70414. doi: 10.1111/cns.70414.
7
Autoimmune encephalitis-associated epilepsy.自身免疫性脑炎相关性癫痫
Nat Rev Neurol. 2025 May 2. doi: 10.1038/s41582-025-01089-4.
8
Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study.自身免疫性脑炎的多模态预后评估:一项澳大利亚自身免疫性脑炎联盟研究。
J Neurol. 2025 Apr 25;272(5):361. doi: 10.1007/s00415-025-13069-1.
9
Neurodegeneration and the immune system: lessons from autoimmune encephalitis.神经退行性变与免疫系统:自身免疫性脑炎的启示
J Neurol. 2025 Apr 24;272(5):359. doi: 10.1007/s00415-025-13094-0.
10
Heterogeneity of clinical features, EEG and brain imaging findings in anti-leucine-rich glioma-inactivated protein 1 autoimmune encephalitis: a retrospective case series study and review of the literature.抗富含亮氨酸胶质瘤失活蛋白1自身免疫性脑炎的临床特征、脑电图及脑影像学表现的异质性:一项回顾性病例系列研究及文献综述
Acta Epileptol. 2023 Aug 15;5(1):21. doi: 10.1186/s42494-023-00132-5.